机构:[1]Peking Univ, Beijing 100871, Peoples R China;[2]Beijing Tian Tan Hosp, Beijing, Peoples R China;[3]Beijing An Zhen Hosp, Beijing, Peoples R China;首都医科大学附属安贞医院[4]China Japan Friendship Hosp, Beijing, Peoples R China;[5]Anhui Med Univ, Hefei, Anhui, Peoples R China;[6]United BioSource Corp, Lexington, MA USA;[7]Pfizer Investment Co Ltd, Beijing, Peoples R China;[8]Pfizer Inc, New York, NY USA;[9]Cornell Univ, New York, NY 10021 USA;[10]Brigham & Womens Hosp, Boston, MA 02115 USA
第一作者机构:[1]Peking Univ, Beijing 100871, Peoples R China;
推荐引用方式(GB/T 7714):
Liu Gordon,Wang Yongjun,Zhao Dong,et al.ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE IN CHINA: A SYSTEMATIC REVIEW[J].HEART.2013,99:E289-E289.doi:10.1136/heartjnl-2013-304613.820.
APA:
Liu, Gordon,Wang, Yongjun,Zhao, Dong,Yang, Wenying,Jiang, Qicheng...&Foody, JoAnne.(2013).ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE IN CHINA: A SYSTEMATIC REVIEW.HEART,99,
MLA:
Liu, Gordon,et al."ECONOMIC BURDEN OF CARDIOVASCULAR DISEASE IN CHINA: A SYSTEMATIC REVIEW".HEART 99.(2013):E289-E289